Maria Jose Cefalu, PA-C

Maria Cefalu practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Maria Cefalu's NPI, 1073714978, was assigned on May 29, 2007. Maria Cefalu holds Washington license PA10003706.

Maria Cefalu's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Maria Cefalu's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. The medical group on file is UW Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Maria Cefalu practices. Vendor and product names are available with a free account.

Physician assistant is Maria Cefalu's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Maria Cefalu is licensed in Washington.

CMS counts 32 Medicare patients who saw Maria Cefalu in 2024. 75% of them have high blood pressure, and 53% have high cholesterol. Their average risk score is 3.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Maria Cefalu's median patient age at 60, with 43% women.

In 2024, Maria Cefalu wrote 67 Medicare Part D claims for 30 patients. 87% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Maria Cefalu for performance year 2024, reported through an alternative payment model (APM). Maria Cefalu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Maria Cefalu from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Genmab U.S., Inc. paid the most, $24.